Sign In
Buy INVVY
$21.85
+0 (+0%)
At Close: Sep 08, 2023
Is Indivior Stock a Buy After Higher 2026 Guidance?
11:16am, Friday, 12'th Jun 2026
Indivior raised 2026 guidance after strong Q1 results, but investors are watching whether Sublocade growth and margin gains can sustain momentum.
Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now
10:55am, Thursday, 14'th May 2026
Indivior Pharmaceuticals Inc. (INDV) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revi
Indivior to Participate in Upcoming Investor Conferences
07:00am, Thursday, 14'th May 2026
RICHMOND, Va., May 14, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences: 2026 Jefferies Gl
Indivior Pharmaceuticals Inc. (INDV) is a Great Momentum Stock: Should You Buy?
01:01pm, Tuesday, 05'th May 2026
Does Indivior Pharmaceuticals Inc. (INDV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Indivior Pharmaceuticals Inc. (INDV) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Tuesday, 05'th May 2026
Indivior Pharmaceuticals Inc. (INDV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the nea
Indivior Announces $175 Million Accelerated Share Repurchase
07:00am, Monday, 04'th May 2026
RICHMOND, Va., May 04, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced that it has entered into a $175 million accelerated share repurchase agreement (“the AS
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call Transcript
08:21pm, Thursday, 30'th Apr 2026
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call Transcript
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
09:35am, Thursday, 30'th Apr 2026
Indivior Pharmaceuticals Inc. (INDV) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.41 per share a year a
Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
07:00am, Thursday, 30'th Apr 2026
Q1'26 Total Net Revenue of $317 Million, Up 19% YoY Q1'26 Total SUBLOCADE® Net Revenue of $232 Million, Up 32% YoY Q1'26 GAAP Net Income of $89 Million and Q1'26 Non-GAAP Net Income of $123 Million R
RICHMOND, Va., April 24, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), a leader in the treatment of opioid use disorder (OUD), will present one new scientific poster and coll
Critical Contrast: Eagle Pharmaceuticals (NASDAQ:EGRX) & Indivior (OTCMKTS:INVVY)
01:44am, Friday, 17'th Apr 2026
Eagle Pharmaceuticals (NASDAQ: EGRX - Get Free Report) and Indivior (OTCMKTS:INVVY - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesse
How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%
10:56am, Friday, 10'th Apr 2026
The consensus price target hints at a 46% upside potential for Indivior Pharmaceuticals Inc. (INDV). While empirical research shows that this sought-after metric is hardly effective, an upward trend i
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
07:00am, Thursday, 09'th Apr 2026
RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026
Indivior: Still Attractive After FY25 Earnings Beat
01:23pm, Monday, 30'th Mar 2026
Indivior has rallied over 300% since 2024 lows, driven by Sublocade market share stability, cost controls, and shareholder activism. INDV remains a 'buy' at a $3.7bn market cap, with management target
Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV)
10:35am, Wednesday, 25'th Mar 2026
The heavy selling pressure might have exhausted for Indivior Pharmaceuticals Inc. (INDV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among W
